All the news Showing 10 of 40 articles from: CirrhosisGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources In ELECTRON trial, 100% of hard-to-treat patients cured with sofosbuvir/ledipasvir plus ribavirin or GS-9669 Liz Highleyman / 05 November 2013 Interferon-free regimens of sofosbuvir and ledipasvir plus either ribavirin or GS-9669 taken for 12 weeks produced sustained response in 100% of treatment-experienced people with genotype 1 chronic hepatitis C virus (HCV) with advanced ... People with HIV/HCV co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease Michael Carter / 10 September 2013 People living with HIV who have hepatitis C virus (HCV) co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease even though they do not have cirrhosis of the liver, ... Decompensated cirrhosis increases risk of liver cancer for people with HIV and viral hepatitis co-infection Michael Carter / 10 September 2013 There is a relatively low incidence of hepatocellular carcinoma (HCC) among people living with HIV who have liver cirrhosis, results of a prospective Spanish study published in the online edition of the ... Probiotics Found To Reduce Hepatic Encephalopathy In Cirrhotic Patients Liver Disease News from Medical News Today / 30 April 2013 New Advances In The Management Of Patients With Cirrhosis Liver Disease News from Medical News Today / 30 April 2013 Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis Keith Alcorn / 30 April 2013 Currently available triple therapies for hepatitis C carry a high risk of serious side-effects for people in the most urgent need of treatment, and these patients have only a moderate chance of being ... EASL publishes first comprehensive literature review on the burden of liver disease in Europe Eurekalert Inf Dis / 22 February 2013 A 'Killer' of a Reason to Treat Hepatitis C: Video Medscape (requires registration) / 18 February 2013 Decompensated liver disease more frequent in HIV/HCV co-infected people Liz Highleyman / 26 July 2012 Despite effective antiretroviral therapy, people co-infected with HIV and hepatitis C remain at higher risk for decompensated liver disease and other liver-related complications than those with hepatitis C alone, according to findings presented on ... BI 201335 & BI 207127 and ribavirin shows good efficacy, including hepatitis C patients with cirrhosis Liz Highleyman / 15 May 2012 An interferon-free regimen of the hepatitis C virus (HCV) protease inhibitor BI 201335, the non-nucleoside polymerase inhibitor BI 207127, and ribavirin produced sustained virological response in 68% of previously untreated genotype 1 hepatitis C ... ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive